Search
for
Sort by
Research 30 of 1000+
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Under Development JAK Inhibitors for Dermatologic Diseases
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- The JAK/STAT signaling pathway: from bench to clinic
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.